Free Trial
NASDAQ:PGNY

Progyny (PGNY) Stock Price, News & Analysis

Progyny logo
$22.41 -1.31 (-5.52%)
As of 12:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Progyny Stock (NASDAQ:PGNY)

Advanced

Key Stats

Today's Range
$22.34
$24.39
50-Day Range
$16.30
$22.25
52-Week Range
$16.10
$28.75
Volume
1.43 million shs
Average Volume
1.53 million shs
Market Capitalization
$1.76 billion
P/E Ratio
29.07
Dividend Yield
N/A
Price Target
$28.18
Consensus Rating
Moderate Buy

Company Overview

Progyny Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
88th Percentile Overall Score

PGNY MarketRank™: 

Progyny scored higher than 88% of companies evaluated by MarketBeat, and ranked 75th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Progyny has received a consensus rating of Moderate Buy. The company's average rating score is 2.85, and is based on 1 strong buy rating, 9 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    Progyny has a consensus price target of $27.91, representing about 18.9% upside from its current price of $23.48.

  • Amount of Analyst Coverage

    Progyny has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Progyny's stock forecast and price target.
  • Earnings Growth

    Earnings for Progyny are expected to grow by 17.86% in the coming year, from $1.12 to $1.32 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Progyny is 30.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.44.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Progyny is 30.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.97.

  • Price to Earnings Growth Ratio

    Progyny has a PEG Ratio of 1.37. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Progyny has a P/B Ratio of 3.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.84% of the float of Progyny has been sold short.
  • Short Interest Ratio / Days to Cover

    Progyny has a short interest ratio ("days to cover") of 4.23.
  • Change versus previous month

    Short interest in Progyny has recently decreased by 9.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Progyny does not currently pay a dividend.

  • Dividend Growth

    Progyny does not have a long track record of dividend growth.

  • News Sentiment

    Progyny has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 23 news articles for Progyny this week, compared to 4 articles on an average week.
  • Search Interest

    Only 2 people have searched for PGNY on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Progyny to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Progyny insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $129,515.00 in company stock.

  • Percentage Held by Insiders

    9.90% of the stock of Progyny is held by insiders.

  • Percentage Held by Institutions

    94.93% of the stock of Progyny is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Progyny's insider trading history.
Receive PGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Progyny and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PGNY Stock News Headlines

Progyny, Inc. 2026 Q1 - Results - Earnings Call Presentation
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
Progyny surges 19% on strong earnings beat
Why is Progyny (PGNY) stock soaring today
Progyny (PGNY) Q1 2026 Earnings Call Transcript
Progyny, Inc. (PGNY) Q1 2026 Earnings Call Transcript
See More Headlines

PGNY Stock Analysis - Frequently Asked Questions

Progyny's stock was trading at $25.68 at the start of the year. Since then, PGNY shares have decreased by 8.6% and is now trading at $23.4750.

Progyny, Inc. (NASDAQ:PGNY) released its quarterly earnings data on Thursday, May, 7th. The company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of $0.26 by $0.03. The business's revenue for the quarter was down 26.4% compared to the same quarter last year.
Read the conference call transcript
.

Progyny (PGNY) raised $150 million in an initial public offering on Friday, October 25th 2019. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan, Goldman Sachs and BofA Merrill Lynch acted as the underwriters for the IPO and Citigroup, Piper Jaffray, SVB Leerink and TPG Capital were co-managers.

Top institutional investors of Progyny include Fort Washington Investment Advisors Inc. OH (3.44%), Dimensional Fund Advisors LP (2.01%), Principal Financial Group Inc. (0.71%) and Bank of New York Mellon Corp (0.57%). Insiders that own company stock include Tpg Gp A, Llc, Peter Anevski, Michael E Sturmer, David J Schlanger, Allison Swartz, Mark S Livingston, Cheryl Scott and Kevin K Gordon.
View institutional ownership trends
.

Shares of PGNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Progyny investors own include Humana (HUM), American Water Works (AWK), NVIDIA (NVDA), Rambus (RMBS), Voyager Therapeutics (VYGR), Saia (SAIA) and Waste Connections (WCN).

Company Calendar

Last Earnings
5/07/2026
Today
5/11/2026
Bank of America Global Healthcare Conference 2026
5/12/2026
AGM 2026
5/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PGNY
CIK
1551306
Fax
N/A
Employees
310
Year Founded
2008

Price Target and Rating

High Price Target
$35.00
Low Price Target
$19.00
Potential Upside/Downside
+25.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.85
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.77
Trailing P/E Ratio
29.15
Forward P/E Ratio
20.07
P/E Growth
1.37
Net Income
$58.52 million
Net Margins
5.23%
Pretax Margin
8.18%
Return on Equity
13.34%
Return on Assets
9.03%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.13
Quick Ratio
2.73

Sales & Book Value

Annual Sales
$1.29 billion
Price / Sales
1.36
Cash Flow
$0.70 per share
Price / Cash Flow
32.22
Book Value
$5.99 per share
Price / Book
3.75

Miscellaneous

Outstanding Shares
78,329,000
Free Float
70,574,000
Market Cap
$1.76 billion
Optionable
Optionable
Beta
0.91

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:PGNY) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners